scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YEBEH.2014.03.018 |
P698 | PubMed publication ID | 24742983 |
P2093 | author name string | Yoshiaki Yamamoto | |
Yukitoshi Takahashi | |||
Yushi Inoue | |||
Kazumi Matsuda | |||
Yoshiyuki Kagawa | |||
Katsumi Imai | |||
Yukiko Mogami | |||
Masahiko Nakai | |||
P2860 | cites work | Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group | Q28138394 |
Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism. | Q34208762 | ||
Inhibition of phenytoin metabolism by sulthiame in epileptic patients | Q34451296 | ||
Phenytoin intoxication induced by sulthiame in epileptic patients | Q37097628 | ||
Sulthiame in refractory paediatric epilepsies: an experience of an 'old' antiepileptic drug in a tertiary paediatric neurology unit. | Q37933761 | ||
Stiripentol open study in Japanese patients with Dravet syndrome | Q42625679 | ||
Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy | Q46605318 | ||
Sulthiame therapy for continuous spike and wave in slow-wave sleep | Q48491640 | ||
Influence of CYP2C19 polymorphism and concomitant antiepileptic drugs on serum clobazam and N-desmethyl clobazam concentrations in patients with epilepsy. | Q51000131 | ||
Benign partial epilepsy--treatment with sulthiame | Q69930570 | ||
Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB | Q80519547 | ||
P304 | page(s) | 124-126 | |
P577 | publication date | 2014-04-17 | |
P1433 | published in | Epilepsy Behavior | Q15746410 |
P1476 | title | Interaction between sulthiame and clobazam: sulthiame inhibits the metabolism of clobazam, possibly via an action on CYP2C19. | |
P478 | volume | 34 |
Q53835626 | Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. |
Q52667006 | PharmGKB summary: clobazam pathway, pharmacokinetics. |
Q36365500 | Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6. |
Q90020510 | Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents |
Search more.